ArticleFrontiers in pharmacology2023
Not one, but many: developing a multi-indication pricing model for medicines in Belgium.
Ingrid Maes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it